Jim Cramer Recommends Eli Lilly Over Viking Therapeutics

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer was asked about. Mentioning that they are a long-term ...
The Motley Fool

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

Viking soared more than 100% in one trading session last year on positive clinical trial news. The stock has since given up those gains, but its weight loss drug program continues to advance and ...
AOL

Down 34%, Should You Buy the Dip on Viking Therapeutics?

Viking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. The biotech might eventually compete against pharma giants Eli Lilly and Novo Nordisk. Early last ...
Business Insider

Viking Analytics enters frame agreement with ABB

STOCKHOLM, Feb. 8, 2021 /PRNewswire/ -- Viking Analytics, a Swedish startup in the field of advanced analytics for predictive operations, has signed a frame agreement with ABB. The scope of the ...